Replimune Group, Inc. — Director's Dealing 2018

Dec 17, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Replimune Group, Inc. (REPL)
CIK: 0001737953
Period of Report: 2018-12-13

Reporting Person: Esposito Pamela (Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-13	Common Stock	M	87000	$1.75	Acquired	87000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-13	Employee Stock Option (right to buy)	$1.75	M	87000	Disposed	2026-03-01	Common Stock (87000)	Direct

Footnotes

F1: The reporting person was granted a stock option to acquire 196,162 shares of the Issuer's common stock, subject to vesting. 134,846 shares underlying the stock option have vested with the remaining 61,316 shares underlying the stock option to vest in 15 equal monthly installments as of the 29th of each month.